BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

547 related articles for article (PubMed ID: 26482189)

  • 1. A novel platform for cancer therapy using extracellular vesicles.
    Tominaga N; Yoshioka Y; Ochiya T
    Adv Drug Deliv Rev; 2015 Dec; 95():50-5. PubMed ID: 26482189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-derived EVs show tropism for tissues at early stage of neoplastic transformation.
    Garofalo M; Villa A; Brunialti E; Crescenti D; Dell'Omo G; Kuryk L; Vingiani A; Mazzaferro V; Ciana P
    Nanotheranostics; 2021; 5(1):1-7. PubMed ID: 33391971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicle-based therapeutics: Extracellular vesicles as therapeutic targets and agents.
    Takahashi Y; Takakura Y
    Pharmacol Ther; 2023 Feb; 242():108352. PubMed ID: 36702209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Focus on Extracellular Vesicles: Development of Extracellular Vesicle-Based Therapeutic Systems.
    Ohno S; Drummen GP; Kuroda M
    Int J Mol Sci; 2016 Feb; 17(2):172. PubMed ID: 26861303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterologous and cross-species tropism of cancer-derived extracellular vesicles.
    Garofalo M; Villa A; Crescenti D; Marzagalli M; Kuryk L; Limonta P; Mazzaferro V; Ciana P
    Theranostics; 2019; 9(19):5681-5693. PubMed ID: 31534511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Micromanaging of tumor metastasis by extracellular vesicles.
    Tominaga N; Katsuda T; Ochiya T
    Semin Cell Dev Biol; 2015 Apr; 40():52-9. PubMed ID: 25746922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives.
    Ou YH; Liang J; Czarny B; Wacker MG; Yu V; Wang JW; Pastorin G
    Semin Cancer Biol; 2021 Sep; 74():45-61. PubMed ID: 33609664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment.
    Kooijmans SAA; Schiffelers RM; Zarovni N; Vago R
    Pharmacol Res; 2016 Sep; 111():487-500. PubMed ID: 27394168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic Use of Tumor Cell-Derived Extracellular Vesicles.
    Liu J; Ma J; Tang K; Huang B
    Methods Mol Biol; 2017; 1660():433-440. PubMed ID: 28828677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of Extracellular Vesicles: Pathobiological Roles in Disease.
    Yamamoto S; Azuma E; Muramatsu M; Hamashima T; Ishii Y; Sasahara M
    Cell Struct Funct; 2016 Nov; 41(2):137-143. PubMed ID: 27679938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Membrane Derived Vesicles as Biomimetic Carriers for Targeted Drug Delivery System.
    Zhang LY; Yang X; Wang SB; Chen H; Pan HY; Hu ZM
    Curr Top Med Chem; 2020; 20(27):2472-2492. PubMed ID: 32962615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicles as an efficient nanoplatform for the delivery of therapeutics.
    Liu C; Gao H; Lv P; Liu J; Liu G
    Hum Vaccin Immunother; 2017 Nov; 13(11):2678-2687. PubMed ID: 28949786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases.
    Rufino-Ramos D; Albuquerque PR; Carmona V; Perfeito R; Nobre RJ; Pereira de Almeida L
    J Control Release; 2017 Sep; 262():247-258. PubMed ID: 28687495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor-derived extracellular vesicles: reliable tools for Cancer diagnosis and clinical applications.
    Rahbarghazi R; Jabbari N; Sani NA; Asghari R; Salimi L; Kalashani SA; Feghhi M; Etemadi T; Akbariazar E; Mahmoudi M; Rezaie J
    Cell Commun Signal; 2019 Jul; 17(1):73. PubMed ID: 31291956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice.
    Garofalo M; Villa A; Rizzi N; Kuryk L; Rinner B; Cerullo V; Yliperttula M; Mazzaferro V; Ciana P
    J Control Release; 2019 Jan; 294():165-175. PubMed ID: 30557650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gold nanoparticle based double-labeling of melanoma extracellular vesicles to determine the specificity of uptake by cells and preferential accumulation in small metastatic lung tumors.
    Lara P; Palma-Florez S; Salas-Huenuleo E; Polakovicova I; Guerrero S; Lobos-Gonzalez L; Campos A; Muñoz L; Jorquera-Cordero C; Varas-Godoy M; Cancino J; Arias E; Villegas J; Cruz LJ; Albericio F; Araya E; Corvalan AH; Quest AFG; Kogan MJ
    J Nanobiotechnology; 2020 Jan; 18(1):20. PubMed ID: 31973696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular Vesicles as Drug Delivery Systems - Methods of Production and Potential Therapeutic Applications.
    Surman M; Drożdż A; Stępień E; Przybyło M
    Curr Pharm Des; 2019; 25(2):132-154. PubMed ID: 30848183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Application of engineered extracellular vesicles for targeted tumor therapy.
    Zhang F; Guo J; Zhang Z; Duan M; Wang G; Qian Y; Zhao H; Yang Z; Jiang X
    J Biomed Sci; 2022 Feb; 29(1):14. PubMed ID: 35189894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicles as emerging targets in cancer: Recent development from bench to bedside.
    Wu K; Xing F; Wu SY; Watabe K
    Biochim Biophys Acta Rev Cancer; 2017 Dec; 1868(2):538-563. PubMed ID: 29054476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering extracellular vesicles for cancer therapy: recent advances and challenges in clinical translation.
    Li S; Xu J; Qian J; Gao X
    Biomater Sci; 2020 Dec; 8(24):6978-6991. PubMed ID: 33155579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.